Cargando…
PD-L1-directed PlGF/VEGF blockade synergizes with chemotherapy by targeting CD141(+) cancer-associated fibroblasts in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) has a poor 5-year overall survival rate. Patients with PDAC display limited benefits after undergoing chemotherapy or immunotherapy modalities. Herein, we reveal that chemotherapy upregulates placental growth factor (PlGF), which directly activates cancer-asso...
Autores principales: | Kim, Duk Ki, Jeong, Juhee, Lee, Dong Sun, Hyeon, Do Young, Park, Geon Woo, Jeon, Suwan, Lee, Kyung Bun, Jang, Jin-Young, Hwang, Daehee, Kim, Ho Min, Jung, Keehoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588060/ https://www.ncbi.nlm.nih.gov/pubmed/36272973 http://dx.doi.org/10.1038/s41467-022-33991-6 |
Ejemplares similares
-
PlGF, immune system and hypertension
por: Carnevale, Daniela, et al.
Publicado: (2015) -
Concentrations of VEGF and PlGF Decrease in Eyes After Intravitreal Conbercept Injection
por: Zhou, Jun, et al.
Publicado: (2018) -
Physical activity differentially regulates VEGF, PlGF, and their receptors in the human placenta
por: Bhattacharjee, Jayonta, et al.
Publicado: (2021) -
PlGF Immunological Impact during Pregnancy
por: Albonici, Loredana, et al.
Publicado: (2020) -
A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome
por: Stepan, H., et al.
Publicado: (2016)